0      0

31st Annual North American Cystic Fibrosis Conference

S04 - S04: INF/MIC: Antimicrobial Agents: What's New?

Nov 2, 2017 2:00pm ‐ Nov 2, 2017 3:25pm


This session will review currently available new antibiotics as well as drugs and compounds currently under development for the treatment of pulmonary infections in individuals with cystic fibrosis.

Learning Objectives:

  1. Describe the antibiotics used in novel ways as well as newly available antibiotics in the treatment of pulmonary infections.
  2. Discuss development and early clinical trials of gallium as an antimicrobial in CF patients.
  3. Examine the mechanism of action and development of antimicrobial peptides as a therapeutic agent for individuals with CF.

Symposium Chair(s):

Symposium Speaker(s):

You must be logged in and own this session in order to post comments.